1. Home
  2. RCKY vs ADAG Comparison

RCKY vs ADAG Comparison

Compare RCKY & ADAG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Rocky Brands Inc.

RCKY

Rocky Brands Inc.

HOLD

Current Price

$33.49

Market Cap

273.7M

ML Signal

HOLD

Logo Adagene Inc.

ADAG

Adagene Inc.

HOLD

Current Price

$3.58

Market Cap

254.4M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
RCKY
ADAG
Founded
1932
2011
Country
United States
China
Employees
N/A
N/A
Industry
Shoe Manufacturing
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
273.7M
254.4M
IPO Year
1996
2020

Fundamental Metrics

Financial Performance
Metric
RCKY
ADAG
Price
$33.49
$3.58
Analyst Decision
Buy
Strong Buy
Analyst Count
1
4
Target Price
$40.00
$8.25
AVG Volume (30 Days)
68.7K
151.8K
Earning Date
04-28-2026
04-01-2026
Dividend Yield
1.71%
N/A
EPS Growth
94.74
N/A
EPS
0.17
N/A
Revenue
$270,408,000.00
N/A
Revenue This Year
$8.12
N/A
Revenue Next Year
$4.90
N/A
P/E Ratio
$195.12
N/A
Revenue Growth
N/A
N/A
52 Week Low
$20.28
$1.44
52 Week High
$48.70
$4.75

Technical Indicators

Market Signals
Indicator
RCKY
ADAG
Relative Strength Index (RSI) 32.98 45.25
Support Level $31.86 $3.40
Resistance Level $34.36 $3.99
Average True Range (ATR) 2.01 0.28
MACD -0.57 -0.01
Stochastic Oscillator 14.13 54.48

Price Performance

Historical Comparison
RCKY
ADAG

About RCKY Rocky Brands Inc.

Rocky Brands Inc is a designer, manufacturer, and marketer of premium footwear and apparel under brands such as Muck, XTRATUF, Rocky, Durango, Georgia Boot, Lehigh, Ranger, and the licensed brand Michelin. The company operates through three segments, with the wholesale segment generating the majority of revenue through sales of footwear and accessories to sporting goods stores, outdoor specialty stores, online retailers, marine stores, independent retailers, mass merchants, retail uniform stores, and specialty safety shoe stores. The retail segment focuses on direct-to-consumer sales through e-commerce platforms and company-operated stores, while the contract manufacturing segment includes sales to the U.S. military, private label production, and sourcing arrangements for customers.

About ADAG Adagene Inc.

Adagene Inc is a platform-driven, clinical-stage biotechnology company focused on the discovery and development of novel antibody-based cancer immunotherapies. The Company leverages computational biology to design and develop novel antibodies. Powered by its Dynamic Precision Library (DPL) platform, which fuels its NEObody, SAFEbody, and POWERbody technologies, it is developing a pipeline of immunotherapies. Its candidate, ADG126 (muzastotug), an anti-CTLA-4 SAFEbody, is in phase 1b/2 and phase 2 clinical development for metastatic microsatellite-stable colorectal cancer. Its clinical-stage products include ADG126 and ADG116, investigational fully human anti-CTLA-4 mAbs generated through SAFEbody and NEObody technologies.

Share on Social Networks: